Skip to main content
. 2010 Feb 12;5:12. doi: 10.1186/1748-717X-5-12

Table 2.

Non-hematologic criteria for dose delay and dose modification of sorafenib (except for skin toxicity)#

Grade Dose Delay Dose Modification
Grade 0-2 Treat on time No Change
Grade 3 Delay* until ≤ Grade 2 Decrease one dose level^
Grade 4

#: Also excludes nausea/vomiting that has not been premedicated, and diarrhea.

*: If no recovery after 30-day delay, treatment will be discontinued.

^: If more than 2 dose reductions are required, treatment will be discontinued.